Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922023 · ClinicalTrials.gov registry record · NA
Management of Uncontrolled Hypertension (HTN)
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02922023 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 2 participants.
The verdict
NCT02922023, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
In this study, investigators will compare chronotherapy to ABPM. Data collected will include hypertension drug therapy regimen prior to and during the study, timing of medication administration, and dose, along with the patient's office blood pressure values prior to study and one month after modification in therapy. This will enable us to explore whether it is a practical endeavor to implement ABPM as a routine process for all uncontrolled hypertension patients or whether ABPM does not seem to provide considerable value over shifting the timing of drug administration.
Interventions
- DEVICE Ambulatory blood pressure monitor (ABPM)
- OTHER Chronotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-01 |
| Est. Completion | 2021-06-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02922023
The ClinicalTrials.gov registry entry for NCT02922023 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ambulatory blood pressure monitor (ABPM) is the first listed.
NCT02922023 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02922023 about?
NCT02922023 is a clinical study titled "Management of Uncontrolled Hypertension (HTN)". In this study, investigators will compare chronotherapy to ABPM. Data collected will include hypertension drug therapy regimen prior to and during the study, timing of medication administration, and dose, along with the patient's office blood pressure values prior to study and one month after modifi...
What is the current status of trial NCT02922023?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-01. Estimated completion is 2021-06-25.
What interventions are being tested in trial NCT02922023?
The interventions under investigation include: Ambulatory blood pressure monitor (ABPM) (DEVICE), Chronotherapy (OTHER).
Who is sponsoring clinical trial NCT02922023?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.